NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 13,240
-760 (-5.43%)
Jun 2, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 160.1 billion as of June 3, 2026.
Market Cap
160.10B
Enterprise Value
141.88B
Revenue
2.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,240.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 160.10B, a decrease of -31.28%. That is a compound annual growth rate of -35.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 160.10B | -38.17% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.09T |
| Celltrion | 40.43T |
| ALTEOGEN | 19.75T |
| Samsung Epis Holdings | 12.04T |
| CMG Pharmaceutical | 182.73B |
| JW Lifescience | 175.90B |
| Jeil Pharmaceutical Co.,Ltd | 172.38B |
| Hana Pharm | 169.20B |